메뉴 건너뛰기




Volumn 136, Issue 3, 2012, Pages 955-962

Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder

Author keywords

Pharmacogenomics; Posttraumatic stress disorder; Selective serotonin reuptake inhibitor; Serotonin transporter gene polymorphism; Serotonin transporter protein; Sertraline

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUVOXAMINE; PAROXETINE; REBOXETINE; SEROTONIN TRANSPORTER; SERTRALINE;

EID: 84857360680     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.08.033     Document Type: Article
Times cited : (34)

References (32)
  • 1
    • 0344896572 scopus 로고    scopus 로고
    • 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study
    • B. Arias, R. Catalan, C. Gasto, B. Gutierrez, and L. Fananas 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study Journal of Clinical Psychopharmacology 23 2003 563 567
    • (2003) Journal of Clinical Psychopharmacology , vol.23 , pp. 563-567
    • Arias, B.1    Catalan, R.2    Gasto, C.3    Gutierrez, B.4    Fananas, L.5
  • 5
    • 8144220483 scopus 로고    scopus 로고
    • Treatment-resistant posttraumatic stress disorder: Strategies for intervention
    • M.B. Hamner, S. Robert, and B.C. Frueh Treatment-resistant posttraumatic stress disorder: strategies for intervention CNS Spectrums 9 2004 740 752
    • (2004) CNS Spectrums , vol.9 , pp. 740-752
    • Hamner, M.B.1    Robert, S.2    Frueh, B.C.3
  • 7
    • 34347374871 scopus 로고    scopus 로고
    • Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression
    • X.Z. Hu, A.J. Rush, D. Charney, A.F. Wilson, A.J. Sorant, and G.J. Papanicolaou Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression Archives of General Psychiatry 64 2007 783 792
    • (2007) Archives of General Psychiatry , vol.64 , pp. 783-792
    • Hu, X.Z.1    Rush, A.J.2    Charney, D.3    Wilson, A.F.4    Sorant, A.J.5    Papanicolaou, G.J.6
  • 10
    • 33749335980 scopus 로고    scopus 로고
    • Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression
    • H. Kim, S.W. Lim, S. Kim, J.W. Kim, Y.H. Chang, B.J. Carroll, and D.K. Kim Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression JAMA 13 2006 1609 1618
    • (2006) JAMA , vol.13 , pp. 1609-1618
    • Kim, H.1    Lim, S.W.2    Kim, S.3    Kim, J.W.4    Chang, Y.H.5    Carroll, B.J.6    Kim, D.K.7
  • 14
    • 84856323143 scopus 로고    scopus 로고
    • Serotonin transporter gene polymorphism and treatment response to Serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study
    • M.A. Margoob, D. Mushtaq, I. Murtaza, H. Mushtaq, and A. Ali Serotonin transporter gene polymorphism and treatment response to Serotonin reuptake inhibitor (escitalopram) in depression: an open pilot study Indian Journal of Psychiatry 50 2008 47 50
    • (2008) Indian Journal of Psychiatry , vol.50 , pp. 47-50
    • Margoob, M.A.1    Mushtaq, D.2    Murtaza, I.3    Mushtaq, H.4    Ali, A.5
  • 15
    • 65049084627 scopus 로고    scopus 로고
    • Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression
    • E. Maron, A. Tammiste, K. Kallassalu, T. Eller, V. Vasar, D.J. Nutt, and A. Metspalu Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression European Neuropsychopharmacology 19 2009 451 456
    • (2009) European Neuropsychopharmacology , vol.19 , pp. 451-456
    • Maron, E.1    Tammiste, A.2    Kallassalu, K.3    Eller, T.4    Vasar, V.5    Nutt, D.J.6    Metspalu, A.7
  • 16
    • 0035189776 scopus 로고    scopus 로고
    • Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo controlled study
    • R.D. Marshall, K.L. Beebe, and M. Oldham Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo controlled study The American Journal of Psychiatry 158 2001 1982 1988
    • (2001) The American Journal of Psychiatry , vol.158 , pp. 1982-1988
    • Marshall, R.D.1    Beebe, K.L.2    Oldham, M.3
  • 17
    • 7744233997 scopus 로고    scopus 로고
    • Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression
    • G.M. Murphy Jr.; S.B. Hollander, H.E. Rodrigues, C. Kremer, and A.F. Schatzberg Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression Archives of General Psychiatry 61 2004 1163 1169
    • (2004) Archives of General Psychiatry , vol.61 , pp. 1163-1169
    • Murphy, Jr.G.M.1    Hollander, S.B.2    Rodrigues, H.E.3    Kremer, C.4    Schatzberg, A.F.5
  • 18
    • 0028145779 scopus 로고
    • Pharmacogenetic response to antidepressants in a multicase family with affective disorder
    • R.L. O'Reilly, L. Bogue, and S.M. Singh Pharmacogenetic response to antidepressants in a multicase family with affective disorder Biological Psychiatry 36 1994 467 471
    • (1994) Biological Psychiatry , vol.36 , pp. 467-471
    • O'Reilly, R.L.1    Bogue, L.2    Singh, S.M.3
  • 23
    • 23144436298 scopus 로고    scopus 로고
    • The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments
    • A. Serretti, F. Benedetti, R. Zanardi, and E. Smeraldi The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 2005 1074 1084
    • (2005) Progress in Neuro-Psychopharmacology & Biological Psychiatry , vol.29 , pp. 1074-1084
    • Serretti, A.1    Benedetti, F.2    Zanardi, R.3    Smeraldi, E.4
  • 24
    • 33847257284 scopus 로고    scopus 로고
    • Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
    • A. Serretti, M. Kato, D. De Ronchi, and T. Kinoshita Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients Molecular Psychiatry 12 2007 247 257
    • (2007) Molecular Psychiatry , vol.12 , pp. 247-257
    • Serretti, A.1    Kato, M.2    De Ronchi, D.3    Kinoshita, T.4
  • 25
    • 0031736757 scopus 로고    scopus 로고
    • Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
    • E. Smeraldi, R. Zanardi, F. Benedetti, D. Di Bella, J. Perez, and M. Catalano Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine Molecular Psychiatry 3 1998 508 511
    • (1998) Molecular Psychiatry , vol.3 , pp. 508-511
    • Smeraldi, E.1    Zanardi, R.2    Benedetti, F.3    Di Bella, D.4    Perez, J.5    Catalano, M.6
  • 26
    • 0001771785 scopus 로고
    • Psychometric properties of the clinicians administered PTSD scale, CAPS-I
    • F.W. Weathers, and B.T. Litz Psychometric properties of the clinicians administered PTSD scale, CAPS-I PTSD Research Quarterly 5 1994 2 6
    • (1994) PTSD Research Quarterly , vol.5 , pp. 2-6
    • Weathers, F.W.1    Litz, B.T.2
  • 29
    • 0036931893 scopus 로고    scopus 로고
    • Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders
    • Y.W. Yu, S.J. Tsai, T.J. Chen, C.H. Lin, and C.J. Hong Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders Molecular Psychiatry 7 2002 1115 1119
    • (2002) Molecular Psychiatry , vol.7 , pp. 1115-1119
    • Yu, Y.W.1    Tsai, S.J.2    Chen, T.J.3    Lin, C.H.4    Hong, C.J.5
  • 30
    • 0033984363 scopus 로고    scopus 로고
    • Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene
    • R. Zanardi, F. Benedetti, D. Di Bella, M. Catalano, and E. Smeraldi Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene Journal of Clinical Psychopharmacology 20 2000 105 107
    • (2000) Journal of Clinical Psychopharmacology , vol.20 , pp. 105-107
    • Zanardi, R.1    Benedetti, F.2    Di Bella, D.3    Catalano, M.4    Smeraldi, E.5
  • 31
    • 0035450812 scopus 로고    scopus 로고
    • Factors affecting fluvoxamine antidepressant activity: Influence of pindolol and 5-HTTLPR in delusional and nondelusional depression
    • R. Zanardi, A. Serretti, D. Rossini, L. Franchini, C. Cusin, E. Lattuada, D. Dotoli, and E. Smeraldi Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression Biological Psychiatry 5 2001 323 330
    • (2001) Biological Psychiatry , vol.5 , pp. 323-330
    • Zanardi, R.1    Serretti, A.2    Rossini, D.3    Franchini, L.4    Cusin, C.5    Lattuada, E.6    Dotoli, D.7    Smeraldi, E.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.